Introduction
Materials and methods
Study design, location, and patients
Data collection and measurement
Outcome parameters
Statistics and ethical review
Results
Basic characteristics
Main population | Sepsis population | |||
---|---|---|---|---|
♂ | ♀ | ♂ | ♀ | |
n = 400 | n = 309 | n = 197 | n = 130 | |
Age (years) | 66 (51|72)a | 68 (54|78)a | 64 (50|72)a | 68 (57|78)a |
Drug abuse | 18 (4.5%)a | 3 (1.0%)a | 14 (7.1)a | 1 (0.8)a |
Nicotine abuse | 56 (14.0%)a | 15 (4.9%)a | 25 (12.7) | 9 (6.9) |
Alcohol abuse | 55 (13.8%)a | 10 (3.2%)a | 33 (16.8)a | 8 (6.2)a |
Preexisting comorbidity | ||||
Immunosuppressive status | 27 (6.8%) | 31 (10.0%) | 11 (5.6%)a | 18 (13.8%)a |
Vascular disease | 202 (50.5%)a | 111 (35.9%)a | 100 (50.8%)a | 45 (34.6%)a |
Hypertension | 178 (44.5%) | 147 (47.6%) | 82 (41.6%) | 60 (46.2%) |
Chronic liver disease | 32 (8.0%) | 16 (5.2%) | 17 (8.6%) | 8 (6.2%) |
Chronic renal disease | 67 (16.8%) | 46 (14.9%) | 37 (18.8%) | 24 (18.5%) |
Metabolic disease | 172 (43.0%) | 141 (45.6%) | 102 (51.8%) | 71 (54.6%) |
Chronic lung disease | 45 (11.3%) | 37 (12.0%) | 27 (13.7%) | 20 (15.4%) |
Psychiatric disease | 81 (20.3%) | 47 (15.2%) | 53 (26.9%) | 31 (23.8%) |
Admission category | ||||
Infection | 14 (3.5%) | 10 (3.2%) | 10 (5.1%) | 7 (5.4%) |
Malignant tumor | 65 (16.3%) | 80 (25.9%) | 27 (13.7%) | 21 (16.2%) |
Neurology | 43 (10.8%) | 34 (11.0%) | 23 (11.7%) | 20 (15.4%) |
Cardiovascular | 154 (38.5%) | 90 (29.1%) | 67 (34.0%) | 34 (26.2%) |
Respiratory | 21 (5.3%) | 17 (5.5%) | 15 (7.6%) | 16 (12.3%) |
Gastrointestinal | 30 (7.5%) | 19 (6.1%) | 20 (10.2%) | 9 (6.9%) |
Trauma | 42 (10.5%) | 29 (9.4%) | 23 (11.7%) | 11 (8.5%) |
Others | 31 (7.8%) | 30 (9.7%) | 12 (6.1%) | 12 (9.2%) |
Surgical patients | 327 (81.8%) | 262 (84.8%) | 151 (76.6%) | 100 (76.9%) |
OP category of surgical patients | ||||
Neurosurgical | 38 (11.6%) | 40 (15.3%) | 19 (12.6%) | 19 (19.0%) |
Musculoskeletal | 59 (18.0%) | 46 (17.6%) | 33 (21.9%) | 19 (19.0%) |
Cardiac | 134 (41.0%) | 65 (24.8%) | 52 (34.4%) | 20 (20.0%) |
Abdomen and urogenital | 83 (25.4%) | 97 (37.0%) | 41 (27.2%) | 30 (30.0%) |
Thorax | 9 (2.8%) | 9 (3.4%) | 4 (2.6%) | 7 (7.0%) |
Soft tissue and others | 4 (1.2%) | 5 (1.9%) | 2 (1.3%) | 5 (5.0%) |
Severity of disease scorings | ||||
SAPS-II on admission | 35 (26|47) | 34 (26|45) | 39 (28|51) | 40 (29|53) |
SOFA on admission | 5 (2|8)a | 4 (2|7)a | 6 (4|9)a | 5 (3|7)a |
TISS-28 on admission | 35 (26|42) | 33 (27|40) | 37 (29|44) | 35 (28|41) |
Diagnostic patterns | ||||
Microbiologic diagnostics (% of LOS) | 17.0 (± 20.4) | 14.9 (± 19.8) | 27.6 (± 19.3) | 24.3 (± 17.3) |
Radiologic diagnostics of (% of LOS) | 55.2 (± 30.0)a | 51.1 (± 31.0)a | 52.1 (± 23.0)a | 45.4 (± 21.3)a |
Antibiotic therapy | ||||
SOP adherence (% of LOS) | 77.3 (± 32.6) | 79.0 (± 33.2) | 68.9 (± 34.4) | 69.3 (± 36.4) |
DAU in agents per day | 1.0 (0.5|1.5) | 1.0 (0.5|1.5) | 1.26 (± 0.65) | 1.18 (± 0.74) |
Antibiotic-free days (% of LOS) | 28.8 (± 27.9) | 27.3 (± 27.6) | 22.0 (± 22.4) | 25.4 (± 24.3) |
Daily costs for antibiotics in € | 19.3 (± 25.5) | 15.6 (± 21.6) | 30.7 (± 28.6) | 26.7 (± 27.1) |
Duration of treatment | ||||
ICU stay in days | 4 (2|11) | 4 (2|9.5) | 10 (5|19) | 10 (5|20) |
Invasive ventilation in hoursb | 27 (11|121)a | 20 (8|95)a | 96 (22|305) | 85 (16|300) |
Diagnostic efforts, patterns of infections, and antibiotic therapy
Main population | Sepsis population | |||
---|---|---|---|---|
♂ | ♀ | ♂ | ♀ | |
Number | 400 | 309 | 197 | 130 |
Patients with infections n (%) | 248 (62.0%)a | 164 (53.1%)a | 197 (100%) | 130 (100%) |
Colitis, pseudomembranous | 2 (0.5%) | 3 (1.0%) | 2 (1.0%) | 2 (1.5%) |
Pneumonia | 135 (33.8%)a | 75 (24.3%)a | 124 (62.9%) | 70 (53.8%) |
Lower urinary tract infections | 13 (3.3%)a | 34 (11.0%)a | 11 (5.6%)a | 30 (23.1%)a |
Bones and joints | 11 (2.8%) | 7 (2.3%) | 8 (4.1%) | 6 (4.6%) |
Endocarditis | 11 (2.8%) | 7 (2.3%) | 10 (5.1%) | 6 (4.6%) |
Abdomen | 40 (10.0%) | 28 (9.1%) | 32 (16.2%) | 18 (13.8%) |
Soft tissue and wounds | 80 (20.0%) | 47 (15.2%) | 55 (27.9%) | 38 (29.2%) |
Upper urinary tract infections | 6 (1.5%) | 4 (1.3%) | 3 (1.5%) | 1 (0.8%) |
Meningitis | 5 (1.3%) | 5 (1.6%) | 4 (2.0%) | 3 (2.3%) |
Bloodstream infection | 35 (8.8%) | 17 (5.5)%) | 34 (17.3%) | 16 (12.3%) |
Fever of unknown origin | 33 (8.3%) | 24 (7.8%) | 22 (11.2%) | 17 (13.1%) |
Catheter-related infections | 17 (4.3%) | 5 (1.6%) | 17 (8.6%) | 5 (3.8%) |
SIRS occurrence n (%) | 364 (91.0%) | 290 (93.9%) | 197 (100%) | 130 (100%) |
Sepsis occurrence n (%) | 197 (49.3%) | 130 (42.1%) | 197 (100%) | 130 (100%) |
Severe sepsis occurrence n (%) | 89 (22.3%)a | 48 (15.5%)a | 89 (45.2%) | 48 (36.9%) |
Septic shock occurrence n (%) | 74 (18,5%) | 41 (13,3%) | 74 (37.6%) | 41 (31.5%) |
Fungi detected | 64 (16.0%) | 47 (15.2%) | 61 (31.0%) | 42 (32.3%) |
Gram-negative germs detected | 98 (24.5%) | 58 (18.8%) | 89 (45.2%) | 52 (40.0%) |
Difficult-to-treat bacteria detected | 41 (10.3%) | 28 (9.1%) | 37 (18.8%) | 26 (20.0%) |
Time to antibiotic therapy
Mortality
Logistic regression analysis
Univariate logistic analysis | Multivariate logistic analysis | |||
---|---|---|---|---|
Parameter | OR (95% CI) |
P
| OR (95% CI) |
P
|
Gender ♀ vs. ♂ | 1.209 (0.735-1.988) | 0.455 | 1.277 (0.720-2.264) | 0.403 |
Age | 1.035 (1.015-1.055) | < 0.001 | 1.041 (1.018-1.064) | < 0.001 |
Alcohol abuse | 1.341 (0.611-2.943) | 0.464 | ||
Nicotine abuse | 0.526 (0.186-1.490) | 0.227 | ||
Drug abuse | 0.976 (0.222-4.280) | 0.974 | ||
Immune suppression | 0.668 (0.234-1.904) | 0.450 | ||
TISS-28 first | 1.080 (1.053-1.108) | < 0.001 | 1.066 (1.035-1.097) | < 0.001 |
Infection during ICU stay | 3.881 (1.745-8.633) | 0.001 | 1.269 (0.487-3.304) | 0.626 |
Infection type | ||||
Pneumonia | 4.370 (2.613-7.311) | < 0.001 | 1.377 (0.676-2.802) | 0.378 |
Urinary tract infection | 1.694 (0.728-3.941) | 0.221 | ||
Abdomen | 1.477 (0.698-3.127) | 0.308 | ||
Bones and joints | 1.164 (0.262-5.173) | 0.842 | ||
Endocarditis | 1.164 (0.262-5.173) | 0.842 | ||
Meningitis | 1.031 (0.129-8.262) | 0.977 | ||
Wounds/soft issue | 1.310 (0.713-2.404) | 0.384 | ||
BSI | 2.338 (0.258-21.220) | 0.450 | ||
Colitis, pseudomembranous | 2.338 (0.258-21.220) | 0.450 | ||
Infection of unknown origin | 0.883 (0.341-2.292) | 0.799 | ||
Severe sepsisa | 4.110 (2.448-6.900) | < 0.001 | ||
Septic shock | 5.023 (2.963-8.515) | < 0.001 | 2.746 (1.328-5.680) | 0.006 |
ICU diagnoses | ||||
Infection | 2.553 (0.922-7.068) | 0.071 | ||
Neoplastic | 0.556 (0.269-1.149) | 0.113 | ||
Neurologic | 0.348 (0.107-1.134) | 0.08 | ||
Cardiovascular | 1.170 (0.700-1.956) | 0.548 | ||
Respiratory | 4.306 (2.032-9.125) | < 0.001 | 1.447 (0.542-3.860) | 0.461 |
Gastrointestinal | 1.322 (0.542-3.229) | 0.540 | ||
Trauma | 0.526 (0.186-1.490) | 0.227 | ||
Miscellaneous | 0.815 (0.315-2.108) | 0.673 | ||
Postoperative admission | 0.865 (0.457-1.637) | 0.655 | ||
Type of surgery | ||||
Head | 0.905 (0.399-2.053) | 0.811 | ||
Musculoskeletal | 0.972 (0.481-1.967) | 0.938 | ||
Cardiac | 1.136 (0.661-1.951) | 0.645 | ||
Abdomen/urogenital | 0.658 (0.351-1.233) | 0.191 | ||
Thorax | 1.164 (0.262-5.173) | 0.842 | ||
Soft tissues and peripheral vascular | 4.803 (1.174-19.651) | 0.029 | 3.509 (0.613-20.073) | 0.158 |
Fungi detected | 4.255 (2.492-7.266) | < 0.001 | 1.398 (0.701-2.788) | 0.341 |
Gram-negative bacteria detected | 2.929 (1.748-4.906) | < 0.001 | 1.234 (0.605-2.513) | 0.563 |
Difficult-to-treat pathogens detectedb | 2.421 (1.248-4.697) | 0.009 | 1.115 (0.499-2.493) | 0.791 |
SOP adherence ≤65% | 1.705 (1.011-2.874) | 0.045 | 2.309 (1.182-4.511) | 0.014 |
Univariate logistic analysis | Multivariate logistic analysis | |||
---|---|---|---|---|
Parameter | OR (95% CI) |
P
| OR (95% CI) |
P
|
Gender ♀ vs. ♂ | 1.889 (1.062-3.359) | 0.030 | 1.909 (1.002-3.638) | 0.049 |
Age | 1.036 (1.014-1.059) | 0.001 | 1.037 (1.013-1.063) | 0.003 |
Alcohol abuse | 0.972 (0.408-2.317) | 0.948 | ||
Nicotine abuse | 0.428 (0.126-1.453) | 0.174 | ||
Drug abuse | 0.719 (0.158-3.277) | 0.670 | ||
Immune suppression | 0.740 (0.247-2.214) | 0.590 | ||
TISS-28 first | 1.063 (1.033-1.093) | < 0.001 | 1.062 (1.028-1.098) | < 0.001 |
Infection type | ||||
Pneumonia | 1.960 (1.048-3.664) | 0.035 | 1.120 (0.539-2.324) | 0.762 |
Urinary tract infection | 0.790 (0.316-1.977) | 0.614 | ||
Abdomen | 1.047 (0.477-2.298) | 0.908 | ||
Bones and joints | 0.782 (0.170-3.593) | 0.752 | ||
Endocarditis | 0.665 (0.147-3.010) | 0.596 | ||
Meningitis | 0.786 (0.093-6.655) | 0.825 | ||
Wounds/Soft issue | 0.787 (0.408-1.519) | 0.476 | ||
BSI | 1.589 (0.162-15.560) | 0.691 | ||
Colitis, pseudomembranous | 1.589 (0.162-15.560) | 0.691 | ||
Infection of unknown origin | 0.667 (0.249-1.788) | 0.421 | ||
Severe sepsisa | 1.845 (1.037-3.280) | 0.037 | ||
Septic shock | 2.418 (1.354-4.319) | 0.003 | 1.649 (0.854-3.184) | 0.136 |
ICU diagnoses | ||||
Infection | 1.492 (0.468-4.755) | 0.499 | ||
Neoplastic | 0.939 (0.414-2.130) | 0.880 | ||
Neurologic | 0.319 (0.095-1.071) | 0.065 | ||
Cardiovascular | 1.146 (0.624-2.107) | 0.660 | ||
Respiratory | 2.523 (1.117-5.699) | 0.026 | 1.374 (0.521-3.620) | 0.520 |
Gastrointestinal | 1.263 (0.490-3.259) | 0.629 | ||
Trauma | 0.428 (0.126-1.453) | 0.174 | ||
Miscellaneous | 0.943 (0.310-2.873) | 0.918 | ||
Postoperative admission | 1.165 (0.581-2.336) | 0.667 | ||
Type of surgery | ||||
Head | 1.079 (0.450-2.589) | 0.864 | ||
Musculoskeletal | 0.573 (0.232-1.414) | 0.227 | ||
Cardiac | 1.335 (0.691-2.577) | 0.390 | ||
Abdomen/Urogenital | 0.954 (0.474-1.919) | 0.894 | ||
Thorax | 1.055 (0.222-5.016) | 0.947 | ||
Soft tissues and peripheral vascular | 3.694 (0.804-16.981) | 0.093 | ||
Fungi detected | 2.297 (1.282-4.118) | 0.005 | 1.523 (0.782-2.968) | 0.216 |
Gram-negative bacteria detected | 1.341 (0.756-2.379) | 0.315 | ||
Difficult-to-treat pathogens detectedb | 1.300 (0.652-2.594) | 0.457 | ||
SOP adherence ≤65% | 1.139 (0.632-2.052) | 0.664 |
Multivariate logistic analysis | ||
---|---|---|
Parameter | OR (95% CI) |
P
|
Gender ♀ vs. ♂ | 1.966 (1.045-3.701) | 0.036 |
Age | 1.038 (1.013-1.063) | 0.002 |
TISS-28 first | 1.069 (1.036-1.103) | < 0.001 |
Septic shock | 1.831 (0.977-3.432) | 0.059 |
Analysis of the progressive course of scoring system TISS-28
Discussion
Limitations
Conclusions
Key messages
-
Gender-related effect on mortality is limited to the specific subgroup of sepsis patients.
-
Quality and quantity of key interventions in infection management are distributed equally between genders.
-
ICU scoring systems should take gender into account as an independent factor for mortality.